Recommendation ID
IPG418/2
Question
NICE also encourages data collection and publication of outcomes on all patients having percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for resistant hypertension. Clinicians should submit data on all patients having this procedure to the national register when it becomes available.
Any explanatory notes
(if applicable)
Current evidence on percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for resistant hypertension is from limited numbers of patients, but there is evidence of efficacy in the short and medium term. There is inadequate evidence on efficacy in the long term; this is particularly important for a procedure aimed at treating resistant hypertension. The limited evidence suggests a low incidence of serious periprocedural complications, but there is inadequate evidence on long-term safety. Therefore this procedure should only be used with special arrangements for clinical governance, consent, and audit or research.

Source guidance details

Comes from guidance
Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for resistant hypertension
Number
IPG418
Date issued
January 2012

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No